123 related articles for article (PubMed ID: 7741926)
1. Beneficial effects of preventive oral administration of camostate on cerulein-induced pancreatitis in rats.
Kisfalvi K; Papp M; Friess H; Büchler M; Gorácz UG
Dig Dis Sci; 1995 Mar; 40(3):546-7. PubMed ID: 7741926
[No Abstract] [Full Text] [Related]
2. [Protective effect of camostat mesilate and allopurinol in acute edematous pancreatitis in the rat induced by excessive doses of caerulein].
Yamasaki Y; Kuroshima T; Tsuji K; Kawamoto H; Higashimoto Y
Nihon Shokakibyo Gakkai Zasshi; 1987 Jul; 84(7):1498. PubMed ID: 3682249
[No Abstract] [Full Text] [Related]
3. Beneficial effects of the synthetic trypsin inhibitor camostate in cerulein-induced acute pancreatitis in rats.
Otsuki M; Tani S; Okabayashi Y; Fuji M; Nakamura T; Fujisawa T; Itoh H
Dig Dis Sci; 1990 Feb; 35(2):242-50. PubMed ID: 1689237
[TBL] [Abstract][Full Text] [Related]
4. Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats.
Tagami H; Abe S; Yoshida Y; Tanaka I; Kamei C
Biol Pharm Bull; 1998 Mar; 21(3):227-30. PubMed ID: 9556150
[TBL] [Abstract][Full Text] [Related]
5. Effect of camostate administration for two weeks on experimental pancreatitis in mice and rats.
Leonhardt U; Seidensticker F; Stöckmann F; Creutzfeldt W
Pancreas; 1993 Jan; 8(1):98-102. PubMed ID: 7678329
[TBL] [Abstract][Full Text] [Related]
6. Effect of FOY-305 (camostate) on severe acute pancreatitis in two experimental animal models.
Lankisch PG; Pohl U; Göke B; Otto J; Wereszczynska-Siemiatkowska U; Gröne HJ; Rahlf G
Gastroenterology; 1989 Jan; 96(1):193-9. PubMed ID: 2909420
[TBL] [Abstract][Full Text] [Related]
7. Camostate (FOY-305) improves the therapeutic effect of peritoneal lavage on taurocholate induced pancreatitis.
Leonhardt U; Seidensticker F; Fussek M; Stöckmann F; Creutzfeldt W
Gut; 1990 Aug; 31(8):934-7. PubMed ID: 2387520
[TBL] [Abstract][Full Text] [Related]
8. Effect of T-0632, a cholecystokininA receptor antagonist, on experimental acute pancreatitis.
Taniguchi H; Yomota E; Kume E; Shikano T; Endo T; Nagasaki M
Jpn J Pharmacol; 1997 Feb; 73(2):105-12. PubMed ID: 9074944
[TBL] [Abstract][Full Text] [Related]
9. Effect of a low-molecular weight serine proteinase inhibitor (camostate) on amylase release from isolated pancreatic acini.
Göke B; Leferink J; Göke R; Adler G
Res Exp Med (Berl); 1989; 189(1):33-8. PubMed ID: 2469115
[TBL] [Abstract][Full Text] [Related]
10. Chronic oral administration of synthetic trypsin inhibitor camostate reduces amylase release from isolated rat pancreatic acini.
Otsuki M; Fujii M; Nakamura T; Tani S; Okabayashi Y
Int J Pancreatol; 1995 Oct; 18(2):135-43. PubMed ID: 8530829
[TBL] [Abstract][Full Text] [Related]
11. Oral administration of sepimostat mesilate prevents acute alcohol pancreatic injury in rats.
Yuasa C; Irimura K; Oda M; Fukui K; Oka T
J Pharm Pharmacol; 1999 Jul; 51(7):867-71. PubMed ID: 10467964
[TBL] [Abstract][Full Text] [Related]
12. Effect of FOY-305 (Camostate) on severe acute pancreatitis in two experimental animal models.
Redmond HP; Leahy AL; Keane FB; Tanner WA
Gastroenterology; 1989 Dec; 97(6):1600. PubMed ID: 2583426
[No Abstract] [Full Text] [Related]
13. The protective effects of long-acting recombinant human pancreatic secretory trypsin inhibitor (R44S-PSTI) in a rat model of cerulein-induced pancreatitis.
Chen YZ; Ikei S; Yamaguchi Y; Sameshima H; Sugita H; Moriyasu M; Ogawa M
J Int Med Res; 1996; 24(1):59-68. PubMed ID: 8674801
[TBL] [Abstract][Full Text] [Related]
14. Prevention of experimental acute pancreatitis by intraduodenal trypsin inhibitor in rat.
Ono H; Hayakawa T; Kondo T; Shibata T; Kitagawa M; Sakai Y; Kiriyama S; Sobajima H
Dig Dis Sci; 1990 Jun; 35(6):787-92. PubMed ID: 2344814
[TBL] [Abstract][Full Text] [Related]
15. Gabexate mesilate (FOY) protects against ceruletide-induced acute pancreatitis in the rat.
Wisner JR; Renner IG; Grendell JH; Niederau C; Ferrell LD
Pancreas; 1987; 2(2):181-6. PubMed ID: 2442741
[TBL] [Abstract][Full Text] [Related]
16. Combination therapy of trypsin inhibitor with ursodeoxycholic acid on cholesterol gallbladder stone.
Tanno N; Ishizuka J; Shimoda I; Sato K; Hirano H; Koizumi M; Toyota T
Gastroenterol Jpn; 1989 Jun; 24(3):339. PubMed ID: 2744348
[No Abstract] [Full Text] [Related]
17. Intracellular action of an exogenous low-molecular-weight synthetic protease inhibitor, E3123, in cerulein-induced acute pancreatitis in rats.
Sata N; Atomi Y; Kimura W; Kuroda A; Muto T; Mineo C
Int J Pancreatol; 1994 Apr; 15(2):119-27. PubMed ID: 8071570
[TBL] [Abstract][Full Text] [Related]
18. Effect of a specific serine protease inhibitor on the rat pancreas: systemic administration of camostate and exocrine pancreatic secretion.
Göke B; Stöckmann F; Müller R; Lankisch PG; Creutzfeldt W
Digestion; 1984; 30(3):171-8. PubMed ID: 6209186
[TBL] [Abstract][Full Text] [Related]
19. The protective effect of the trypsin inhibitor urinastatin on cerulein-induced acute pancreatitis in rats.
Tani S; Otsuki M; Itoh H; Nakamura T; Fujii M; Okabayashi Y; Fujisawa T; Baba S
Pancreas; 1988; 3(4):471-6. PubMed ID: 2459695
[TBL] [Abstract][Full Text] [Related]
20. Effects of a new cholecystokinin antagonist, TS-941, on experimental acute pancreatitis in rats.
Wang Y; Naruse S; Kitagawa M; Ishiguro H; Nakae Y; Yoshikawa T; Hayakawa T
Pancreas; 1998 Oct; 17(3):289-94. PubMed ID: 9788544
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
